Skip to main content Back to Top
Advertisement

7/10/2019

Hydroxyzine Pamoate Oral Capsules

Products Affected - Description

    • Vistaril oral capsule, Pfizer, 25 mg, bottle, 100 count, NDC 00069-5410-66
    • Vistaril oral capsule, Pfizer, 50 mg, bottle, 100 count, NDC 00069-5420-66
    • Hydroxyzine pamoate oral capsule, Amneal, 25 mg, bottle, 100 count, NDC 00115-1803-01
    • Hydroxyzine pamoate oral capsule, Amneal, 25 mg, bottle, 500 count, NDC 00115-1803-02
    • Hydroxyzine pamoate oral capsule, Amneal, 50 mg, bottle, 100 count, NDC 00115-1804-01
    • Hydroxyzine pamoate oral capsule, Amneal, 50 mg, bottle, 500 count, NDC 00115-1804-02

Reason for the Shortage

    • Amneal did not provide a reason for the shortage.
    • Mylan refuses to provide availability updates.
    • Pfizer did not provide a reason for the shortage.
    • Rising discontinued hydroxyzine pamoate capsules.
    • Sandoz did not provide a reason for the shortage.
    • Teva did not provide a reason for the shortage.

Available Products

    • Hydroxyzine pamoate oral capsule, Sandoz, 25 mg, bottle, 100 count, NDC 00185-0674-01
    • Hydroxyzine pamoate oral capsule, Sandoz, 25 mg, bottle, 500 count, NDC 00185-0674-05
    • Hydroxyzine pamoate oral capsule, Sandoz, 50 mg, bottle, 100 count, NDC 00185-0615-01
    • Hydroxyzine pamoate oral capsule, Sandoz, 50 mg, bottle, 500 count, NDC 00185-0615-05
    • Hydroxyzine pamoate oral capsule, Teva, 100 mg, bottle, 100 count, NDC 00555-0324-02
    • Hydroxyzine pamoate oral capsule, Teva, 25 mg, bottle, 100 count, NDC 00555-0323-02
    • Hydroxyzine pamoate oral capsule, Teva, 25 mg, bottle, 500 count, NDC 00555-0323-04
    • Hydroxyzine pamoate oral capsule, Teva, 50 mg, bottle, 100 count, NDC 00555-0302-02
    • Hydroxyzine pamoate oral capsule, Teva, 50 mg, bottle, 500 count, NDC 00555-0302-04

Estimated Resupply Dates

    • Amneal has all hydroxyzine pamoate capsules on back order and the company estimates a release date of late-August 2019.
    • Pfizer has Vistaril 25 mg and 50 mg capsules in 100 count bottles on back order and the company estimates a release date of October 2019 for the 25 mg capsules and August 2019 for the 50 mg capsules.

Updated

Updated July 10, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 14, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins